Table 2.
Descriptive summary of men across all studies
| Country | The Gambia | South Africa | UK | US | US | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | GamBAS | Agincourt a | HCS | HealthABC Black | HealthABC White | ||||||
| Location | Rural | Rural | Urban | Urban | Urban | ||||||
| n participantb (HIVc) | 239 | 258 (34) | 498 | 446 | 846 | ||||||
| Mean (SD) Age | 61.1 (12.3) | 43.8 (16.3) | 69.0 (6.6) | 77.2 (4.0) | 77.9 (4.1) | ||||||
| Median [IQR] BMI | 20.4 [18.8–22.5] | 24.2 [21.4–27.9] | 26.8 [24.6–29.1] | 26.8 [23.9–29.9] | 26.6 [24.5–29.2] | ||||||
| n measurements | 404 | 224a | 1067 | 1743 | 3517 | ||||||
| n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | ||
| Total hip T-score | 40–49 y | 91 | 0.60 (1.14) | 34 | 0.95 (1.17) | – | – | – | – | – | – |
| 50–59 y | 115 | 0.33 (0.93) | 30 | 0.88 (1.40) | 13 | 0.99 (1.06)] | – | – | – | – | |
| 60–69 y | 94 | − 0.39 (1.18) | 41 | 0.64 (1.40) | 651 | 0.59 (1.16)] | 22 | 0.92 (1.26)] | 32 | 0.04 (1.04)] | |
| ≥ 70 y | 104 | − 0.52 (1.33) | 12 | 0.47 (1.38) | 403 | 0.48 (1.32)] | 1716 | 0.29 (1.37)] | 3477 | − 0.32 (1.30)] | |
| Femoral neck T-score | 40–49 y | 91 | 0.94 (1.19) | 34 | 0.63 (1.16) | – | – | – | – | – | – |
| 50–59 y | 115 | 0.49 (0.98) | 30 | 0.40 (1.26) | 13 | − 0.20 (0.873)] | – | – | – | – | |
| 60–69 y | 94 | − 0.28 (0.98) | 41 | − 0.01 (1.48) | 651 | − 0.34 (1.06)] | 22 | 0.16 (1.11)] | 32 | − 0.81 (1.07)] | |
| ≥ 70 y | 104 | − 0.54 (1.32) | 12 | − 0.23 (1.38) | 403 | 0.19 (1.31)] | 1720 | − 0.46 (1.25)] | 3482 | − 1.15 (1.16)] | |
aAgincourt participants were restricted to those aged 40 and over
bFor the prospective cohorts, the baseline number of participants is stated
cHIV data only collected in Agincourt